SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-21-035880
Filing Date
2021-07-07
Accepted
2021-07-07 08:45:39
Documents
1
Period of Report
2021-07-02

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2239
  Complete submission text file 0001213900-21-035880.txt   3681
Mailing Address C/O MARRONE BIO INNOVATIONS, INC. 2121 SECOND STREET, A-107 DAVIS CA 95618
Business Address
Marrone Pamela G (Reporting) CIK: 0001582885 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38105 | Film No.: 211076284

Mailing Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025
Business Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025 650-507-0669
180 Life Sciences Corp. (Issuer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations